global view constructed of white lines

Blog

Glioblastoma and COVID-19
July 1, 2021

Glioblastoma at the Time of COVID-19

by Akanksha Sharma

In February 2020, a beautiful and energetic young woman in her late 30s gave birth to her second child. In the week and months after, the world changed around her. Inside, she felt strange too – exhausted, moody, very irritable, forgetful all the time. Maybe...

Castle Connolly 2021 Top doctors
May 14, 2021

PNI Experts Are 2021 Castle Connolly Top Doctors

by Zara Jethani

The Castle Connolly Top Doctor rigorous selection process is entirely merit-based. For 25 years, Castle Connolly’s mission has been to help people find the best healthcare by connecting patients with best-in-class healthcare providers. They provide an unbiased directory of healthcare providers. Through their extensive research...

Go Gray In May
May 2, 2021

Go Gray in May for Brain Tumor Awareness

by Zara Jethani

Raise awareness for brain tumor treatment and research by wearing GRAY ribbons, clothes, and masks. Be sure to help spread the word to friends, family, and colleagues. A Few Facts about Brain Tumors Approximately 80% of cancers may metastasize to the brain, these include melanoma (where nearly 50% of cases will...

Los Angeles Magazine Top Doctors 2021
April 9, 2021

Pacific Neuroscience Institute Physicians Named “L.A.’s Top Doctors” of 2021

by Caroline Mekhiel

This year, seven of Pacific Neuroscience Institute Medical Group’s physicians were included in Los Angeles Magazine’s April 2021 roster of “L.A.’s Top Doctors.” The results were based on a Los Angeles Magazine survey that asked physicians throughout Los Angeles County to identify the doctors they considered to be...

Oncology Clinical Trials at PNI
March 2, 2021

ONCOLOGY Clinical Trials Round-Up: March 2021

by Mini Gill

New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...

Think Neuro Podcast Cover Dr. Kesari
February 23, 2021

New Hope on Vanquishing Glioblastoma | Dr. Santosh Kesari

by Anthony Effinger

Listen to our conversation with Dr. Kesari to find out what GBM treatments make him believe that big breakthroughs are on the horizon for treating this tricky, and tragic, disease.

PNI 2021
January 1, 2021

PNI Founders’ Message 2021

by Guest Author

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

November Clinical Trials at PNI
December 2, 2020

Clinical Trials Round-Up: December 2020

by Mini Gill

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

November Clinical Trials at PNI
November 2, 2020

Clinical Trials Round-Up: November 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Clinical Trials Round Up October 2020 Cover
October 2, 2020

Clinical Trials Round-Up: October 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Last updated: February 23rd, 2021